MarketsNotableReportedDeveloping
5.9
Brazil pharma stocks plunge up to 10% as Mercado Livre enters prescription drug sales
InfoMoney·BR·3 days ago
Hypera's board approved R$185.2 million in dividends, payable by end of fiscal year 2027. This is a routine capital return decision, with eligibility based on shareholding at record date. The extended payment timeline suggests a deliberate cash management strategy, but no material market impact is expected.